March 23, 2018 / 12:58 PM / 9 months ago

BRIEF-EU Medicines Agency Recommends Approval Of Amgen Europe, Sandoz Biosimilar Drugs

March 23 (Reuters) - EU Medicines Agency:

* EU MEDICINES AGENCY RECOMMENDS APPROVAL OF AMGEN EUROPE'S BIOSIMILAR DRUG FOR TREATMENT OF BREAST AND GASTRIC CANCER

* EU MEDICINES AGENCY RECOMMENDS APPROVAL OF SANDOZ'S BIOSIMILAR DRUG FOR TREATMENT OF RHEUMATOID ARTHRITIS, CROHN'S DISEASE, ULCERATIVE COLITIS, ETC. Source text ID: (bit.ly/2G0h1YI) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below